المؤلفون: Tefferi A; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Fleti F; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Chan O; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Al Ali NH; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Al-Kali A; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Begna KH; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Foran JM; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Badar T; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Khera N; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Shah M; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Hiwase D; Division of Blood Cells and Blood Cancer, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia., Padron E; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Sallman DA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Pardanani A; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Arber DA; Department of Pathology, University of Chicago, Chicago, Illinois, USA., Orazi A; Department of Pathology, Texas Tech University Health Sciences Center, El Paso, Texas, USA., Reichard KK; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., He R; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Ketterling RP; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Gangat N; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Komrokji R; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA.

المصدر: British journal of haematology [Br J Haematol] 2024 Apr; Vol. 204 (4), pp. 1243-1248. Date of Electronic Publication: 2023 Dec 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Myelodysplastic Syndromes*/genetics , Myelodysplastic Syndromes*/therapy , Myelodysplastic Syndromes*/diagnosis, Humans ; Gene Frequency ; Mutation ; Prognosis ; Chromosome Deletion ; Chromosomes, Human, Pair 5/genetics ; Tumor Suppressor Protein p53/genetics

المؤلفون: Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Aguirre LE; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Al Ali NH; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Chan O; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Xie Z; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Kuykendall A; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Sweet K; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Lancet JE; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Padron E; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Sallman DA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

المصدر: Blood advances [Blood Adv] 2023 Jul 25; Vol. 7 (14), pp. 3677-3679.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Anemia*/drug therapy , Anemia*/etiology , Myelodysplastic Syndromes*/complications , Myelodysplastic Syndromes*/drug therapy, Humans ; Immunoglobulin Fc Fragments/therapeutic use ; Activin Receptors, Type II

المؤلفون: Fleti F; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Chan O; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Singh A; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Abdelmagid MG; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Al-Kali A; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Elliott MA; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Begna KH; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Foran JM; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Badar T; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Khera N; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Al Ali NH; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Padron E; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Sallman DA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Shah M; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Hiwase D; Division of Blood Cells and Blood Cancer, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia., Pardanani A; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Arber DA; Department of Pathology, University of Chicago, Chicago, Illinois, USA., Orazi A; Department of Pathology, Texas Tech University Health Sciences Center, El Paso, Texas, USA., Reichard KK; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., He R; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Ketterling RP; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Gangat N; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Komrokji R; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Tefferi A; Mayo Clinic, Rochester, Minnesota, USA.

المصدر: American journal of hematology [Am J Hematol] 2023 Apr; Vol. 98 (4), pp. E76-E79. Date of Electronic Publication: 2023 Feb 06.

نوع المنشور: Letter

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Myelodysplastic Syndromes*/genetics, Humans ; Mutation ; Gene Frequency ; Chromosome Deletion ; Chromosomes, Human, Pair 5/genetics ; Tumor Suppressor Protein p53/genetics

المؤلفون: Mangaonkar AA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester., Lasho TL; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester., Finke C; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester., Ketterling RP; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester., Reichard KK; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester., McCullough K; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester., Gangat N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester., Al-Kali A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester., Begna KH; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Hogan WH; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Litzow MR; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Alkhateeb H; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester., Shah M; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester., Pardanani A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester., Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester., Al Ali NH; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Talati C; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Sallman D; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Padron E; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Komrokji R; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL. Rami.Komrokji@moffitt.org., Patnaik MM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester. patnaik.mrinal@mayo.edu.

المصدر: Haematologica [Haematologica] 2022 May 01; Vol. 107 (5), pp. 1189-1192. Date of Electronic Publication: 2022 May 01.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Myelodysplastic Syndromes*/diagnosis , Myelodysplastic Syndromes*/genetics , Myelodysplastic-Myeloproliferative Diseases*/diagnosis , Myelodysplastic-Myeloproliferative Diseases*/genetics , Neoplasms*, Humans ; Mutation ; Phosphoproteins/genetics ; Prognosis ; RNA Splicing Factors/genetics

المؤلفون: Gajzer D; Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Logothetis CN; University of South Florida, Internal Medicine, Tampa, FL, USA., Sallman DA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Calon G; University of South Florida, College of Medicine, USA., Babu A; University of South Florida, Internal Medicine, Tampa, FL, USA., Chan O; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Vincelette ND; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Volpe VO; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Al Ali NH; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Basra P; Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Talati C; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Kuykendall AT; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Mo Q; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Padron E; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Sweet K; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Lancet JE; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Yun S; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA. Electronic address: Seongseok.Yun@moffitt.org., Zhang L; Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Electronic address: Ling.Zhang@moffitt.org.

المصدر: Leukemia research [Leuk Res] 2021 Dec; Vol. 111, pp. 106733. Date of Electronic Publication: 2021 Oct 21.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5835 (Electronic) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE

مواضيع طبية MeSH: Mutation*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Leukemia, Myeloid, Acute/*pathology , Myelodysplastic Syndromes/*pathology , Neoplasms, Second Primary/*pathology , Proto-Oncogene Proteins c-myc/*metabolism, Adult ; Aged ; Aged, 80 and over ; Disease Progression ; Female ; Follow-Up Studies ; Humans ; Leukemia, Myeloid, Acute/drug therapy ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/metabolism ; Male ; Middle Aged ; Myelodysplastic Syndromes/drug therapy ; Myelodysplastic Syndromes/genetics ; Myelodysplastic Syndromes/metabolism ; Neoplasms, Second Primary/drug therapy ; Neoplasms, Second Primary/genetics ; Neoplasms, Second Primary/metabolism ; Prognosis ; Proto-Oncogene Proteins c-myc/genetics ; Retrospective Studies ; Survival Rate ; Young Adult

المؤلفون: Sallman DA; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., DeZern AE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD., Garcia-Manero G; Department of Leukemia, MD Anderson Cancer Center, Houston, TX., Steensma DP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Roboz GJ; Weill Cornell Medicine and The New York Presbyterian Hospital, New York, NY., Sekeres MA; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH., Cluzeau T; Cote D'Azur University, Nice Sophia Antipolis University, Hematology Department, CHU Nice, Nice, France., Sweet KL; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., McLemore A; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., McGraw KL; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Puskas J; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Zhang L; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Yao J; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Mo Q; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Nardelli L; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Al Ali NH; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Padron E; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Korbel G; Aprea Therapeutics, Boston, MA., Attar EC; Aprea Therapeutics, Boston, MA., Kantarjian HM; Department of Leukemia, MD Anderson Cancer Center, Houston, TX., Lancet JE; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Fenaux P; Hospital St Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., List AF; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Komrokji RS; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 May 10; Vol. 39 (14), pp. 1584-1594. Date of Electronic Publication: 2021 Jan 15.

نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Mutation*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Azacitidine/*administration & dosage , Myelodysplastic Syndromes/*drug therapy , Quinuclidines/*administration & dosage , Tumor Suppressor Protein p53/*genetics, Adult ; Aged ; Aged, 80 and over ; Azacitidine/adverse effects ; Biomarkers, Tumor ; Female ; Humans ; Male ; Middle Aged ; Myelodysplastic Syndromes/genetics ; Myelodysplastic Syndromes/mortality ; Quinuclidines/adverse effects

المؤلفون: Ward GA; Cancer Biology PhD Program, University of South Florida and H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., McGraw KL; Department of Malignant Hematology, and., Abbas-Aghababazadeh F; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Meyer BS; Department of Malignant Hematology, and., McLemore AF; Department of Malignant Hematology, and., Vincelette ND; Department of Malignant Hematology, and., Lam NB; Department of Malignant Hematology, and., Aldrich AL; Department of Malignant Hematology, and., Al Ali NH; Department of Malignant Hematology, and., Padron E; Department of Malignant Hematology, and., Pinilla-Ibarz J; Department of Malignant Hematology, and., Masala E; MDS Unit, Azienda Ospedaliero Universitaria Careggi, University of Florence, Firenze, Italy., Santini V; MDS Unit, Azienda Ospedaliero Universitaria Careggi, University of Florence, Firenze, Italy., Kosmider O; Assistance Publique-Hôpitaux de Paris, Centre-Université de Paris, Service d'Hématologie Biologique, Hôpital Cochin, Paris, France.; Groupe Francophone des Myélodysplasies, Hôpital Saint-Louis, Paris, France., Fontenay M; Assistance Publique-Hôpitaux de Paris, Centre-Université de Paris, Service d'Hématologie Biologique, Hôpital Cochin, Paris, France.; Groupe Francophone des Myélodysplasies, Hôpital Saint-Louis, Paris, France., Fenaux P; Groupe Francophone des Myélodysplasies, Hôpital Saint-Louis, Paris, France.; Service d'Hématologie Séniors, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris and Université Paris 7, Paris, France., Johnson J; Analytic Microscopy Core Facility, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; and., Fridley BL; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., List AF; Raleigh, NC.

المصدر: Blood advances [Blood Adv] 2021 Apr 27; Vol. 5 (8), pp. 2216-2228.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Inflammasomes* , Myelodysplastic Syndromes*/diagnosis , Myelodysplastic Syndromes*/genetics, Animals ; Biomarkers ; DNA, Mitochondrial/genetics ; Humans ; Mice ; Pyroptosis

المؤلفون: Yun S; Malignant Hematology Department, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Geyer SM; Health Informatics Institute, University of South Florida, Tampa, FL, USA., Komrokji RS; Malignant Hematology Department, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Al Ali NH; Malignant Hematology Department, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Song J; Hematopathology and Laboratory Medicine Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Hussaini M; Hematopathology and Laboratory Medicine Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Sweet KL; Malignant Hematology Department, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Lancet JE; Malignant Hematology Department, H. Lee Moffitt Cancer Center, Tampa, FL, USA., List AF; Malignant Hematology Department, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Padron E; Malignant Hematology Department, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Sallman DA; Malignant Hematology Department, H. Lee Moffitt Cancer Center, Tampa, FL, USA. David.Sallman@moffitt.org.

المصدر: Leukemia [Leukemia] 2021 Apr; Vol. 35 (4), pp. 1145-1155. Date of Electronic Publication: 2020 Jul 29.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Disease Susceptibility*, Leukemia, Myeloid, Acute/*etiology , Leukemia, Myeloid, Acute/*mortality , Myelodysplastic Syndromes/*genetics , Myelodysplastic Syndromes/*mortality, Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor ; Computational Biology/methods ; Female ; Genetic Predisposition to Disease ; High-Throughput Nucleotide Sequencing ; Humans ; Leukemia, Myeloid, Acute/diagnosis ; Male ; Middle Aged ; Molecular Sequence Annotation ; Mutation ; Myelodysplastic Syndromes/diagnosis ; Prognosis ; Retrospective Studies ; Survival Analysis

المؤلفون: Kanagal-Shamanna R; Department of Hematopathology and Molecular Diagnostics, Division of Pathology and Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. RKanagal@mdanderson.org., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Katsonis P; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Class CA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Sallman D; Malignant Hematology Department, H. Lee Moffitt Cancer Center, Tampa, FL, United States., Hunter AM; Malignant Hematology Department, H. Lee Moffitt Cancer Center, Tampa, FL, United States., Benton C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Luthra R; Department of Hematopathology and Molecular Diagnostics, Division of Pathology and Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Bueso-Ramos CE; Department of Hematopathology and Molecular Diagnostics, Division of Pathology and Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Andreeff M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Komrokji RS; Malignant Hematology Department, H. Lee Moffitt Cancer Center, Tampa, FL, United States., Al Ali NH; Malignant Hematology Department, H. Lee Moffitt Cancer Center, Tampa, FL, United States., Short N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Routbort MJ; Department of Hematopathology and Molecular Diagnostics, Division of Pathology and Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Khoury JD; Department of Hematopathology and Molecular Diagnostics, Division of Pathology and Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Patel K; Department of Hematopathology and Molecular Diagnostics, Division of Pathology and Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ganan-Gomez I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Wei Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Do KA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Soltysiak KA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Lichtarge O; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States., Medeiros LJ; Department of Hematopathology and Molecular Diagnostics, Division of Pathology and Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

المصدر: Blood cancer journal [Blood Cancer J] 2021 Mar 06; Vol. 11 (3), pp. 52. Date of Electronic Publication: 2021 Mar 06.

نوع المنشور: Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Myelodysplastic Syndromes/*genetics , Tumor Suppressor Protein p53/*genetics, Humans ; Models, Molecular ; Mutation ; Myelodysplastic Syndromes/diagnosis ; Myelodysplastic Syndromes/pathology ; Prognosis

المؤلفون: Komrokji RS; Malignant Hematology Department, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Al Ali NH; Malignant Hematology Department, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Sallman D; Malignant Hematology Department, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Padron E; Malignant Hematology Department, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., DeZern AE; Kimmel Cancer Center/Johns Hopkins University, Baltimore, MD, USA., Barnard J; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA., Roboz GJ; Weill Cornell Medical College, New York, NY, USA., Garcia-Manero G; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., List A; Malignant Hematology Department, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Steensma DP; Dana-Farber Cancer Institute, Boston, MA, USA., Sekeres MA; Leukemia Program, Cleveland Clinic, Cleveland, OH, USA.

المصدر: Cancer medicine [Cancer Med] 2021 Jan; Vol. 10 (2), pp. 447-453. Date of Electronic Publication: 2020 Dec 22.

نوع المنشور: Journal Article; Validation Study

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Response Evaluation Criteria in Solid Tumors*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Hematopoietic Stem Cell Transplantation/*mortality , Myelodysplastic Syndromes/*mortality, Aged ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Male ; Myelodysplastic Syndromes/pathology ; Myelodysplastic Syndromes/therapy ; Remission Induction ; Retrospective Studies ; Survival Rate